|
Maia Biotechnology Inc (MAIA) |
|
Maia Biotechnology Inc
MAIA's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Maia Biotechnology Inc 's sales fell
in III. Quarter 2023 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -4.75 %
Maia Biotechnology Inc net loss decreased from $-5 millions, to $-5 millions in III. Quarter 2023,
• More on MAIA's Growth
|
|
Maia Biotechnology Inc realized a net loss in trailing twelve months.
Maia Biotechnology Inc realized cash reduction of $ -0.58 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.75.
• More on MAIA's Valuation
|
|
|
|
|
Maia Biotechnology Inc realized net loss in trailing twelve months.
Maia Biotechnology Inc realized cash outflow of $ -0.58per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.75.
Maia Biotechnology Inc Price to Book Ratio is at 12.24 lower than Industry Avg. of 84.78. and higher than S&P 500 Avg. of 0
• More on MAIA's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com